GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 76 filers reported holding GAMIDA CELL LTD in Q1 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,320 | +78.0% | 21,786 | +100.0% | 0.00% | – |
| Q2 2022 | $19,281 | -59.0% | 10,893 | -4.0% | 0.00% | -100.0% |
| Q1 2022 | $47,000 | +56.7% | 11,346 | -3.6% | 0.00% | 0.0% |
| Q4 2021 | $30,000 | -30.2% | 11,766 | +7.1% | 0.00% | 0.0% |
| Q3 2021 | $43,000 | +13.2% | 10,990 | +144.2% | 0.00% | -50.0% |
| Q4 2020 | $38,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |